診斷研究綜述：2025

2024 年，全球基於人類微生物組的藥物和診斷市場價值為 3.152 億美元，預計從 2025 年到 2030 年將以 25.6% 的複合年成長率成長，到 2030 年底達到 12 億美元。

2024 年全球分子診斷市場價值為 203 億美元，預計從 2025 年到 2030 年將以 13.1% 的複合年成長率成長，到 2030 年底達到 426 億美元。

2024 年全球非侵入性癌症診斷市場價值 1,128 億美元，預計從 2025 年到 2030 年將以 6.6% 的複合年成長率成長，到 2030 年底達到 1,652 億美元。

儘管近年來經濟狀況嚴峻，診斷業仍維持成長。該行業受到公眾和政府的密切關注和嚴格審查，並因監管力度的加大而經歷許多變革。這些變革在許多國家都有所體現。作為全球最大的診斷市場，美國正主導著旨在降低醫療保健成本的變革。診斷產業蘊藏著許多機遇，尤其是在新興市場（主要位於新興經濟體）湧現之際，這些市場擁有多元化的需求。

醫療保健成本的不斷上漲和新興經濟體的成長正在推動對技術先進的診斷設備、試劑盒、試劑及其他配件的需求。此外，日益嚴格的監管，尤其是在美國和歐洲等已開發市場，正迫使診斷設備製造商推出採用新材料、注重詳細診斷指標並具備產生新數據能力的先進產品。

推動市場發展的主要因素包括慢性病和感染疾病的日益普遍、診斷技術的進步、診斷市場對人工智慧投資的增加、在非腫瘤領域的應用不斷擴大以及個性化醫療的普及。

本研究綜述重點摘錄了BCC Research於2025年發布的診斷相關報告，涵蓋大腸直腸癌篩檢與診斷、腫瘤診斷、液態生物檢體、人類微生物組藥物和分子診斷等領域。報告總結了市場概況、市場影響因素和機會、法律制度、新興技術和發展趨勢、市場規模趨勢和預測，並按不同細分市場和地區進行了詳細分析。

目錄

第1章：序言

第2章：組織診斷：各種技術與全球市場（MDS051B）

• 市場展望
• 調查範圍
• 市場概況
• 市場概覽與定義
• 免疫組織化學（IHC）
• 原位雜合反應
• 聚合酵素鏈鎖反應
• 次世代定序
• 一般培養試驗
• 市場動態
• 市場促進因素
• 市場機遇
• 市場限制因素
• 市場挑戰
• 新興科技與發展
• 市場區隔
• 市場區隔：依產品類型
• 市場區隔：按細分市場
• 組織病理學
• 分子病理學
• 微生物檢測
• 數位病理學
• 市場區隔：按地區
• 北美洲
• 歐洲
• 亞太地區
• 拉丁美洲
• 其他地區
• 組織診斷市場的永續性：從ESG觀點
• ESG概覽
• 環境績效
• 社會表現
• 管治績效
• BCC的結語

第3章：全球大腸癌篩檢與診斷市場（HLC300A）

• 市場展望
• 調查範圍
• 市場洞察
• 市場概覽
• 市場動態
• 市場促進因素
• 市場限制因素
• 市場機遇
• 新興技術
• 全球大腸直腸癌篩檢和診斷檢測服務市場。
• 市場分析：按測試類型
• 大腸鏡檢查及乙狀結腸鏡檢查
• 糞便DNA檢測
• 血液檢測/生物標記檢測
• 大便潛血試驗（FOBT）
• 糞便潛血隱血免疫測定（FIT）
• 市場分析：按地區分類
• 北美洲
• 歐洲
• 亞太地區
• 其他地區
• 大腸直腸癌篩檢和診斷檢測服務市場的永續性
• 永續性
• BCC的結語

第4章 腫瘤診斷：全球市場 (MDS046B)

• 市場展望
• 調查範圍
• 市場概況
• 市場動態與成長要素
• 新興技術
• 細分市場分析
• 區域分析
• 策略舉措
• 結論
• 市場概覽
• 市場動態
• 市場促進因素
• 市場機遇
• 市場限制因素
• 市場挑戰
• 新興技術
• 全球市場洞察
• 市場區隔：依產品類型
• 診斷影像
• 內視鏡設備
• 腫瘤生物標記檢測
• 切片檢查裝置
• 蘇木精-伊紅染色
• 免疫組織化學
• 原位雜合反應
• 聚合酵素鏈鎖反應
• 次世代定序
• 其他
• 市場區隔：按地區
• 重點
• 北美洲
• 歐洲
• 亞太地區
• 南美洲
• 中東和非洲
• 腫瘤診斷市場的永續性：從ESG觀點
• ESG概覽
• ESG績效分析
• BCC的結語

第5章：液態生物檢體的研究工具、服務與診斷（BIO150E）

• 市場展望
• 調查範圍
• 市場概況
• 市場概覽
• 市場動態
• 市場促進因素
• 市場限制因素
• 市場機遇
• 新興技術
• 市場趨勢
• 全球液態生物檢體市場：按應用領域分類
• 非侵入性產前檢測（NIPT）
• 癌症
• 器官移植
• 全球液態生物檢體市場：按地區分類
• 北美洲
• 歐洲
• 亞太地區
• 其他地區
• 液態生物檢體市場的永續性：ESG觀點
• ESG概覽
• 液態生物檢體行業的ESG實踐
• 環境績效
• 社會表現
• 管治績效
• ESG風險評估
• BCC的結語

第6章：基於人類微生物組的藥物和診斷（BIO151B）

• 市場展望
• 調查範圍
• 市場概況
• 市場動態
• 新興技術
• 基於細分市場的分析
• 區域分析
• 結論
• 概述和市場定義
• 市場動態
• 市場促進因素
• 市場限制因素
• 市場機遇
• 新興技術
• 市場分析：按類型
• 基於微生物組的藥物
• 基於微生物組的診斷
• 市場分析：按地區分類
• 北美洲
• 歐洲
• 亞太地區
• 南美洲
• 中東和非洲
• 基於人類微生物組的製藥和診斷行業的永續性：從ESG觀點
• ESG概覽
• ESG風險評估
• BCC的結語

第7章 分子診斷：技術與全球市場 (BIO063F)

• 市場展望
• 調查範圍
• 市場概況
• 市場動態與成長要素
• 新興技術
• 細分市場分析
• 區域分析
• 結論
• 市場概覽
• 市場動態
• 市場促進因素
• 市場限制因素
• 市場機遇
• 新興技術
• 市場分析：按技術分類
• 重點
• 聚合酵素鏈鎖反應（PCR）
• 次世代定序（NGS）
• 原位雜合反應
• 微陣列
• 其他
• 市場分析：依產品/服務分類
• 重點
• 消耗品
• 裝置
• 軟體和服務
• 市場分析：按地區分類
• 重點
• 北美洲
• 歐洲
• 亞太地區
• 其他地區
• 分子診斷市場的永續性：從ESG觀點
• ESG概覽
• 分子診斷產業的ESG實踐
• ESG風險評估
• 結論

第8章 體外診斷：各種技術及全球市場 (HLC186D)

• 市場展望
• 調查範圍
• 市場概況
• 市場動態
• 市場促進因素
• 市場限制因素
• 市場機遇
• 體外診斷市場的新興技術
• 市場分析：按技術分類
• 免疫化學
• 即時檢測
• 血
• 分子診斷
• 組織診斷
• 臨床微生物學
• 市場分析：按地區分類
• 北美洲
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東和非洲
• 體外診斷產業的永續發展：從ESG觀點
• ESG在體外診斷製造的重要性
• 體外診斷產業的ESG實踐
• 環境績效
• 社會表現
• 管治績效
• 企業在ESG發展中的作用
• ESG風險評估
• BCC的結語

第9章：全球過敏診斷與治療市場（PHM026D）

• 市場展望
• 調查範圍
• 市場概況
• 市場動態與成長要素
• 細分市場分析
• 區域分析
• 結論
• 市場概覽
• 市場動態
• 市場促進因素
• 市場限制因素
• 市場機遇
• 新興技術
• 全球過敏診斷與治療市場：按類型分類
• 重點
• 診斷
• 治療
• 全球過敏診斷與治療市場：按藥物類型分類
• 重點
• 處方藥
• 非處方藥
• 全球過敏診斷與治療市場：按地區分類
• 重點
• 北美洲
• 歐洲
• 亞太地區
• 中東和非洲
• 南美洲
• 過敏診斷與治療市場的永續性：ESG觀點
• ESG概覽
• ESG在過敏診斷和治療市場中的作用
• ESG風險評估
• 結論

第10章 非侵入性癌症診斷：各種技術和全球市場（HLC197B）

• 市場展望
• 調查範圍
• 市場概況
• 市場動態與成長要素
• 新興技術
• 細分市場分析
• 區域分析
• 結論
• 當前市場概況
• 市場動態
• 市場促進因素
• 市場限制因素
• 市場機遇
• 市場挑戰
• 新興技術
• 市場分析：依癌症類型分類
• 重點
• 乳癌
• 肺癌
• 結腸癌
• 攝護腺癌
• 子宮頸癌
• 胃癌
• 肝癌
• 食道癌
• 膀胱癌
• 其他
• 市場分析：依技術類型分類
• 重點
• 診斷影像技術
• 先進的非侵入性方法
• 常規非侵入性癌症篩檢、診斷檢測和測試
• 市場分析：按地區分類
• 重點
• 北美洲
• 歐洲
• 亞太地區
• 南美洲
• 中東和非洲
• 全球非侵入性癌症診斷市場的永續性：ESG觀點
• ESG概覽
• 主要製造商：ESG舉措
• BCC的結語

第11章：全球糖尿病治療與診斷市場 (HLC029G)

• 市場展望
• 調查範圍
• 市場概況
• 概述
• 當前市場狀況
• 細分市場分析
• 技術進步
• 結論
• 市場概覽
• 市場動態
• 市場促進因素
• 市場限制因素
• 市場機遇
• 市場挑戰
• 新興技術
• 全球糖尿病治療與診斷市場：按產品分類
• 重點
• 糖尿病藥物
• 糖尿病監測設備及配件
• 胰島素輸注裝置
• 全球糖尿病治療與診斷市場：按地區分類
• 重點
• 北美洲
• 歐洲
• 亞太地區
• 中東和非洲
• 南美洲
• 糖尿病治療與診斷市場的永續性：ESG觀點
• ESG概覽
• 糖尿病藥物和診斷試劑中的ESG
• ESG績效分析
• BCC的結語

第12章附錄

The global market for human microbiome-based drugs and diagnostics was valued at $315.2 million in 2024 and is expected to reach $1.2 billion by the end of 2030, at a CAGR of 25.6% from 2025 to 2030.

The global market for molecular diagnostics was valued at $20.3 billion in 2024 and is expected to reach $42.6 billion by the end of 2030, at a CAGR of 13.1% from 2025 to 2030.

The global market for noninvasive cancer diagnostics was valued at $112.8 billion in 2024 and is projected to reach $165.2 billion by the end of 2030, at a CAGR of 6.6% from 2025 to 2030.

Report Scope

The diagnostics industry has grown despite the challenging economic conditions in recent years. The industry draws much attention and scrutiny from the public and government, and is currently undergoing many changes due to increased focus on regulations. These changes can be seen across many countries. The U.S., the largest diagnostics market, is leading the trend with changes intended to make healthcare more affordable. Opportunities for the diagnostics industry are manifold, with the appearance of new markets located mainly in emerging economies with varying needs.

Increasing healthcare expenditures and the growth of emerging economies have increased the demand for technologically better diagnostic devices, kits, reagents, and other accessories. Additionally, the introduction of more stringent regulations, specifically in the developed markets of the U.S. and Europe, has forced diagnostics manufacturers to launch advanced products that include new materials, a focus on in-depth indications, and the ability to produce additional new data.

Some of the major driving factors in the market are the increasing prevalence of chronic and infectious diseases, technological advances in diagnostics, increasing investments in AI in the diagnostics market, increased applications in non-oncology areas, and growing adoption of personalized medicine.

Furthermore, technically sophisticated diagnostics are needed for clinical research, as the market is highly competitive, and companies must continuously reinvent their product portfolios to enter new markets and place themselves as key participants in the healthcare system. There is a shift toward a value-based healthcare market where price and purchase decisions are based on outcomes. This has further led to increased scrutiny of device technology, and consequently, the degree of competition has risen. Some of the major firms in the diagnostics market include Abbott, Medtronic, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Agilent Technologies Inc., QIAGEN, Danaher Corp., Sysmex, Thermo Fisher Scientific Inc., BD, and others.

The diagnostics industry is a multi-billion-dollar market with an outlook for continued growth in the coming years. Hospital care is growing, and the diagnostics industry is being looked at to provide low-cost technology for home healthcare. Now, the industry seeks healthcare diagnostic devices, kits, and reagents that individuals with unskilled healthcare experience can use. The need for modern technology, equipment, and devices can be leveraged through diagnostic equipment as manufacturers seek to create better-quality healthcare solutions.

The above reasons are compelling enough to analyze and research the diagnostics market, as the market has tremendous growth potential.

It includes highlights from these reports published in 2024:

MDS051B Tissue Diagnostics: Technologies and Global Markets

• HLC300A Global Colorectal Cancer Screening and Diagnostics Market
• MDS046B Oncology Diagnostics: Global Markets
• BIO150E Liquid Biopsy Research Tools, Services, and Diagnostics
• BIO151B Human Microbiome-based Drugs and Diagnostics
• BIO063F Molecular Diagnostics: Technologies and Global Markets
• HLC186D In Vitro Diagnostics: Technologies and Global Markets
• PHM026D Global Markets for Allergy Diagnostics and Treatments
• HLC197B Noninvasive Cancer Diagnostics: Technologies and Global Markets
• HLC029G Global Markets for Diabetes Therapeutics and Diagnostics

After you survey the excerpts in this Research Review, we encourage you to follow up on these topics by checking out the full market research reports associated with each topic. BCC Research looks forward to serving your market intelligence needs in the future.

Table of Contents

Chapter 1 Foreword

• Research Review Scope

Chapter 2 Tissue Diagnostics: Technologies and Global Markets (MDS051B)

• Market Outlook
• Scope of Report
• Market Summary
• Market Overview and Definitions
• Immunohistochemistry (IHC)
• In Situ Hybridization
• Polymerase Chain Reaction
• Next-Generation Sequencing
• General Culture Testing
• Market Dynamics
• Market Drivers
• Market Opportunities
• Market Restraints
• Market Challenges
• Emerging Technologies and Developments
• Market Breakdown
• Market Breakdown by Product Type
• Market Breakdown by Segment
• Histopathology Market
• Molecular Pathology Market
• Microbiology Testing Market
• Digital Pathology Market
• Market Breakdown by Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Rest of the World
• Sustainability in the Market for Tissue Diagnostics: An ESG Perspective
• Introduction to ESG
• Environmental Performance
• Social Performance
• Governance Performance
• Concluding Remarks from BCC

Chapter 3 Global Colorectal Cancer Screening and Diagnostics Market (HLC300A)

• Market Outlook
• Scope of Report
• Market Insights
• Market Overview
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies
• Global Market for Colorectal Cancer Screening and Diagnostic Testing Services
• Market Analysis by Test Type
• Colonoscopy and Sigmoidoscopy Tests
• Stool DNA Tests
• Blood-Based/Biomarker Tests
• Fecal Occult Blood Tests (FOBT)
• Fecal Immunochemical Tests (FIT)
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in the Colorectal Cancer Screening and Diagnostic Testing Service Market
• Introduction
• Sustainability
• Concluding Remarks from BCC

Chapter 4 Oncology Diagnostics: Global Markets (MDS046B)

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Strategic Initiatives
• Conclusion
• Market Overview
• Market Dynamics
• Market Drivers
• Market Opportunities
• Market Restraints
• Market Challenges
• Emerging Technologies
• Global Market Insights
• Market Breakdown by Product Type
• Diagnostics Imaging
• Endoscopy Devices
• Tumor Biomarker Tests
• Biopsy Devices
• Hematoxylin and Eosin
• Immunohistochemistry
• In situ Hybridization
• Polymerase Chain Reaction
• Next-Generation Sequencing
• Others
• Market Breakdown by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa (MEA)
• Sustainability in the Market for Oncology Diagnostics: An ESG Perspective
• Introduction to ESG
• ESG Performance Analysis
• Concluding Remarks from BCC

Chapter 5 Liquid Biopsy Research Tools, Services and Diagnostics (BIO150E)

• Market Outlook
• Scope of Report
• Market Summary
• Market Overview
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies
• Market Trends
• Global Market for Liquid Biopsy by Application
• Non-invasive Prenatal Testing (NIPT)
• Cancer
• Organ Transplantation
• Global Market for Liquid Biopsy by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)
• Sustainability in the Liquid Biopsy Market: ESG Perspective
• Introduction to ESG
• ESG Practices in the Liquid Biopsy Industry
• Environmental Performance
• Social Performance
• Governance Performance
• ESG Risk Ratings
• Concluding Remarks from BCC Research

Chapter 6 Human Microbiome-based Drugs and Diagnostics (BIO151B)

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics
• Emerging Technologies
• Analysis by Segment
• Regional Analysis
• Conclusion
• Overview and Market Definition
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies
• Market Analysis by Type
• Microbiome-based Drugs
• Microbiome-based Diagnostics
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa
• Sustainability in the Human Microbiome-based Drugs and Diagnostics Industry: An ESG Perspective
• Introduction to ESG
• ESG Risk Ratings
• Concluding Remarks

Chapter 7 Molecular Diagnostics: Technologies and Global Markets (BIO063F)

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion
• Market Overview
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies
• Market Analysis by Technology
• Key Takeaways
• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing (NGS)
• In Situ Hybridization
• Microarrays
• Others
• Market Analysis by Product and Service
• Key Takeaways
• Consumables
• Instruments
• Software and Services
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in the Molecular Diagnostics Market: An ESG Perspective
• Introduction to ESG
• ESG Practices in the Molecular Diagnostics Industry
• ESG Risk Ratings
• Conclusion

Chapter 8 In Vitro Diagnostics: Technologies and Global Markets (HLC186D)

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies in the IVD Market
• Market Analysis by Technology
• Immunochemistry
• POC Testing
• Hematology
• Molecular Diagnostics
• Tissue Diagnostics
• Clinical Microbiology
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa
• Sustainability in the In Vitro Diagnostics Industry: An ESG Perspective
• Importance of ESG in In Vitro Diagnostics Manufacturing Industry
• ESG Practices in the In Vitro Diagnostics Industry
• Environmental Performance
• Social Performance
• Governance Performance
• Company Role in ESG Development
• ESG Risk Ratings
• BCC Research Viewpoint

Chapter 9 Global Markets for Allergy Diagnostics and Treatments (PHM026D)

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics and Growth Factors
• Segmental Analysis
• Regional Analysis
• Conclusion
• Market Overview
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies
• Global Allergy Diagnostics and Treatment Market by Type
• Key Takeaways
• Diagnostics
• Treatments
• Global Allergy Diagnostics and Treatment Market by Drug Type
• Key Takeaways
• Prescription Drugs
• Over-the-Counter Drugs
• Global Allergy Diagnostics and Treatment Market by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Middle East and Africa (MEA)
• South America
• Sustainability in the Allergy Diagnostics and Treatment Market:ESG Perspective
• Introduction to ESG
• Role of ESG in the Allergy Diagnostics and Treatment Market
• ESG Risk Ratings
• Conclusion

Chapter 10 Noninvasive Cancer Diagnostics: Technologies and Global Markets (HLC197B)

• Market Outlook
• Scope of the Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion
• Current Market Overview
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Market Challenges
• Emerging Technologies
• Market Analysis by Cancer Type
• Key Takeaways
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Cervical Cancer
• Stomach Cancer
• Liver Cancer
• Esophageal Cancer
• Bladder Cancer
• All Other Cancers
• Market Analysis by Technology Type
• Key Takeaways
• Diagnostic Imaging Technologies
• Advanced Noninvasive Approaches
• Conventional Noninvasive Cancer Screening, Diagnostic Assays and Tests
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa
• Sustainability in Global Noninvasive Cancer Diagnostics Market: An ESG Perspective
• Introduction to ESG
• Major Manufacturers: ESG Efforts
• Concluding Remarks from BCC Research

Chapter 11 Global Markets for Diabetes Therapeutics and Diagnostics (HLC029G)

• Market Outlook
• Scope of Report
• Market Summary
• Overview
• Current Market Scenario
• Segmental Analysis
• Technological Advances
• Conclusion
• Market Overview
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Market Challenges
• Emerging Technologies
• Global Diabetes Therapeutics and Diagnostic Market by Product
• Key Takeaways
• Diabetes Therapeutics
• Diabetes Monitoring Devices and Accessories
• Insulin Delivery Devices
• Global Diabetes Therapeutics and Diagnostic Market by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Middle East and Africa
• South America
• Sustainability in the Diabetes Therapeutics and Diagnostics Market: An ESG Perspective
• Introduction to ESG
• ESG in Diabetes Therapeutics and Diagnostics
• ESG Performance Analysis
• Concluding Remarks from BCC

Chapter 12 Appendix

• Methodology
• Analyst's Credentials

List of Tables

• Table 1 : Global Tissue Diagnostics Market, by Product Type, Through 2029
• Table 2 : Global Incidence of All Cancers, by Region, 2022-2045
• Table 3 : Cancer Cases, by Country, 2022
• Table 4 : Incidence of Cancer, by Cancer Type, 2022
• Table 5 : Global Tissue Diagnostics Market, Through 2029
• Table 6 : Global Tissue Diagnostics Market, by Product Type, Through 2029
• Table 7 : Global Tissue Diagnostics Market, by Segment Type, Through 2029
• Table 8 : Global Tissue Diagnostics Market, by Region, Through 2029
• Table 9 : ESG: Environmental Overview
• Table 10 : ESG: Social Overview
• Table 11 : ESG: Governance Overview
• Table 12 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
• Table 13 : Countries with Highest Colorectal Cancer Incidence and Rates, 2022
• Table 14 : Successful Colorectal Cancer Screening Initiatives, 2004-2011
• Table 15 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, Through 2029
• Table 16 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029
• Table 17 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
• Table 18 : Recent ESG Highlights from Select Testing Services Providing Companies
• Table 19 : ESG Rankings for a Few Service-Providing Companies, 2024
• Table 20 : ESG Rankings for Major Product Manufacturing Companies, 2024
• Table 21 : Global Market for Oncology Diagnostics, by Product Type, Through 2029
• Table 22 : Cancer Treatments Based on Specific Tests
• Table 23 : Select FDA-Approved AI-Associated/Associable-Equipped Medical Devices
• Table 24 : Global Oncology Diagnostics Market, by Product Type, Through 2029
• Table 25 : Global Oncology Diagnostics Market, by Region, Through 2029
• Table 26 : ESG: Environmental Overview
• Table 27 : ESG: Social Overview
• Table 28 : ESG: Governance Overview
• Table 29 : Global Market for Liquid Biopsy, by Region, Through 2029
• Table 30 : Liquid Biopsy Sample Types and Characteristics
• Table 31 : Global Market for Liquid Biopsy, by Application, Through 2029
• Table 32 : Global Market for Liquid Biopsy, by Region, Through 2029
• Table 33 : Key Focus Areas in ESG Metrics
• Table 34 : Environmental Performance Initiatives in the Liquid Biopsy Market
• Table 35 : Social Performance Initiatives in the Liquid Biopsy Market
• Table 36 : Governance Performance Initiatives in the Liquid Biopsy Market
• Table 37 : ESG Rankings for Leaders in the Market for Liquid Biopsy, 2024*
• Table 38 : Global Market for Human Microbiome-based Drugs and Diagnostics, by Region, Through 2030
• Table 39 : Diseases Associated with Microbiome Dysbiosis
• Table 40 : Global Market for Human Microbiome-based Drugs and Diagnostics, by Type, Through 2030
• Table 41 : Global Market for Human Microbiome-based Drugs and Diagnostics, by Region, Through 2030
• Table 42 : ESG Goals of Human Microbiome-based Drugs and Diagnostics Companies
• Table 43 : ESG Risk Ratings for Human Microbiome-based Drugs and Diagnostics Firms, 2025
• Table 44 : Global Molecular Diagnostics Market, by Region, Through 2030
• Table 45 : Global Molecular Diagnostics Market, by Technology, Through 2030
• Table 46 : Global Molecular Diagnostics Market, by Product and Service, Through 2030
• Table 47 : Global Molecular Diagnostics Market, by Region, Through 2030
• Table 48 : Environmental Performance Initiatives in the Molecular Diagnostics Market
• Table 49 : Social Performance Initiatives in the Molecular Diagnostics Market
• Table 50 : Governance Performance Initiatives in the Molecular Diagnostics Market
• Table 51 : ESG Risk Rankings for Molecular Diagnostics Companies, 2025
• Table 52 : Global Market for In Vitro Diagnostics, by Region, Through 2029
• Table 53 : Global Market for In Vitro Diagnostics, by Technology, Through 2029
• Table 54 : Summary of Electrochemiluminescence POCT Devices with Their Analytic Performance
• Table 55 : Global Market for In Vitro Diagnostics, by Region, Through 2029
• Table 56 : ESG Practices: Environmental Performance
• Table 57 : ESG Practices: Social Performance
• Table 58 : ESG Practices: Governance Performance
• Table 59 : Creating an Attractive Workplace: Social Performance
• Table 60 : ESG Rankings for Leading In Vitro Diagnostics Companies, 2023 and 2024*
• Table 61 : Global Market for Allergy Diagnostics and Treatment, by Region, Through 2030
• Table 62 : Global Market for Allergy Diagnostics and Treatment, by Type, Through 2030
• Table 63 : Global Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
• Table 64 : Global Market for Allergy Diagnostics and Treatment, by Region, Through 2030
• Table 65 : ESG Risk Rankings for Allergy Diagnostic and Treatment Market Companies, 2025*
• Table 66 : Global Market for Noninvasive Cancer Diagnostics, by Region, Through 2030
• Table 67 : Types of Liquid Biopsy and Their Clinical Applications, 2024
• Table 68 : Estimated Cancer Incidence, Age (0-85+), 2022-2045
• Table 69 : Estimated Cancer Incidence in Males in the U.S., by Cancer Site, 2025
• Table 70 : Estimated Cancer Incidence in Females in the U.S., by Cancer Site, 2025
• Table 71 : Global Market for Noninvasive Cancer Diagnostics, by Cancer Type, Through 2030
• Table 72 : Global Market for Noninvasive Cancer Diagnostics, by Technology Type, Through 2030
• Table 73 : Global Market for Noninvasive Cancer Diagnostics, by Region, Through 2030
• Table 74 : ESG Highlights, by Major Players, 2024
• Table 75 : Global Market for Diabetes Therapeutics and Diagnostics, by Region, Through 2030
• Table 76 : Indonesia: Price Ranges of Diabetes Monitoring Products, by Sector, 2024
• Table 77 : Selected Technology Integrated Products
• Table 78 : Global Market for Diabetes Therapeutics and Diagnostics, by Product, Through 2030
• Table 79 : Global Revenues of Leading Diabetes-Focused Pharmaceutical Companies,2023 and 2024
• Table 80 : Major Companies: Diabetes Therapeutic Pipeline
• Table 81 : Insulin vs. GLP-1 Therapy
• Table 82 : Standard GLP-1 RAs vs. Dual/Triple Agonists
• Table 83 : Comparison of Different Types of Insulins
• Table 84 : Oral Antidiabetic Drugs Overview
• Table 85 : Blood Glucose Test Strips, by Manufacturer
• Table 86 : Blood Glucose Meters, by Manufacturer
• Table 87 : Continuous Glucose Monitoring Systems, by Manufacturer
• Table 88 : Comparison of Continuous Glucose Monitoring Systems, by Company
• Table 89 : Lancets and Lancet Devices, by Manufacturer
• Table 90 : Insulin Infusion Pumps, by Manufacturer
• Table 91 : Insulin Pen, by Manufacturer
• Table 92 : Global Market for Diabetes Therapeutics and Diagnostics, by Region, Through 2030
• Table 93 : Diabetes Waste Management Recommendations
• Table 94 : ESG Rankings for Diabetes Therapeutics and Diagnostics Companies, 2025*
• Table 95 : ESG: Environmental Overview
• Table 96 : ESG: Social Overview
• Table 97 : ESG: Governance Overview

List of Figures

• Figure 1 : Shares of Global Market for Tissue Diagnostics, by Product Type, 2023
• Figure 2 : Shares of All Cancer Cases, by Region, 2022
• Figure 3 : Shares of Global Market for Tissue Diagnostics, by Segment Type, 2023
• Figure 4 : Shares of Global Market for Tissue Diagnostics, by Region, 2023
• Figure 5 : ESG Pillars
• Figure 6 : Advantages of ESG for Companies
• Figure 7 : Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Region, 2023
• Figure 8 : Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, 2023
• Figure 9 : Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Region, 2023
• Figure 10 : Snapshot of ESG Pillars
• Figure 11 : Global Market Shares of Oncology Diagnostics, by Product Type, 2023
• Figure 12 : Number of FDA-Approved Companion Diagnostic Devices, 1997-2024
• Figure 13 : Share of Global Market for Oncology Diagnostics, by Product Type, 2023
• Figure 14 : Share of Global Market for Oncology Diagnostics, by Region, 2023
• Figure 15 : ESG Pillars
• Figure 16 : Advantages of ESG for Companies
• Figure 17 : Global Market Shares of Liquid Biopsy, by Application 2024
• Figure 18 : Estimated Number of New Cancer Cases Globally, 2022, 2045 and 2050
• Figure 19 : Global Market Shares of Liquid Biopsy, by Region, 2024
• Figure 20 : How a Strong ESG Proposition Benefits Businesses?
• Figure 21 : Global Market Shares of Human Microbiome-based Drugs and Diagnostics, by Region, 2024
• Figure 22 : Diseases and Conditions Associated with Dysbiosis
• Figure 23 : Global Market Shares of Human Microbiome-based Drugs and Diagnostics, by Type, 2024
• Figure 24 : Global Market Shares of Human Microbiome-based Drugs and Diagnostics, by Region, 2024
• Figure 25 : Global Molecular Diagnostics Market Shares, by Region, 2024
• Figure 26 : Global Molecular Diagnostics Market Shares, by Technology, 2024
• Figure 27 : Global Molecular Diagnostics Market Shares, by Product and Service, 2024
• Figure 28 : Global Molecular Diagnostics Market Shares, by Region, 2024
• Figure 29 : Key ESG Metrics of Molecular Diagnostics Companies
• Figure 30 : Global Market Shares of In Vitro Diagnostics, by Region, 2023
• Figure 31 : Emerging AI Applications in In Vitro Diagnostics
• Figure 32 : Global Market Shares of In Vitro Diagnostics, by Technology, 2023
• Figure 33 : Global Market Shares of In Vitro Diagnostics, by Region, 2023
• Figure 34 : SNAPSHOT: Key ESG Trends in the In Vitro Diagnostics Industry
• Figure 35 : Global Market Shares of Allergy Diagnostic and Treatments, by Region, 2024
• Figure 36 : Global Market Shares of Allergy Diagnostics and Treatment, by Type, 2024
• Figure 37 : Global Market Shares of Allergy Diagnostics and Treatment, by Drug Type, 2024
• Figure 38 : Global Market Shares of Allergy Diagnostics and Treatment, by Region, 2024
• Figure 39 : Pillars of ESG
• Figure 40 : Advantages of ESG for Companies
• Figure 41 : Global Market Shares for Noninvasive Cancer Diagnostics, by Region, 2024
• Figure 42 : Global Market Shares for Noninvasive Cancer Diagnostics, by Cancer Type, 2024
• Figure 43 : Global Market Shares for Noninvasive Cancer Diagnostics, by Technology Type, 2024
• Figure 44 : Global Market Shares for Noninvasive Cancer Diagnostics, by Region, 2024
• Figure 45 : Pillars of Sustainable Cancer Care
• Figure 46 : :Global Market Shares for Diabetes Therapeutics and Diagnostics, by Region, 2024
• Figure 47 : DIABETES: Type
• Figure 48 : Estimated Number of People Aged 20 to 79 With Diabetes, Globally, 2000-2024
• Figure 49 : Global Market Shares for Diabetes Therapeutics and Diagnostics, by Product, 2024
• Figure 50 : Global Market Shares for Diabetes Therapeutics and Diagnostics, by Region, 2024
• Figure 51 : ESG Pillars
• Figure 52 : Advantages of ESG for Companies
• Figure 53 : Diabetes Therapeutics and Diagnostics: Key ESG Issues